Population
87-year-old female Croatian/Caucasian patient, alongside a review of 8 previously reported cases of…
Design
Case_report
Authors
Loading...
May warrant caution with rosuvastatin-ticagrelor in patients with multiple inactivating alleles; leaves open need for prospective validation before practice change.
Concomitant use of rosuvastatin and ticagrelor may lead to rhabdomyolysis, particularly in elderly patients with polypharmacy, renal impairment, and specific pharmacogenetic predispositions.
Kirhmajer et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: